There is no greater honor than recognition by your peers, and it was a career highlight for me to serve as President of the American Thyroid Association (ATA) in 2014. The Mayo Clinic has always had a very strong thyroid group, beginning with Henry Plummer, who described toxic multinodular goiter (also known as Plummer's disease) in 1913, and Edward Kendall, who isolated thyroxine 100 years ago in 1914, before discovering cortisone in 1946, for which he received the Nobel Prize in Medicine in 1950. This year, I
was proud and fortunate to serve as the 10th ATA President from Mayo as we celebrated the 91st ATA anniversary.
The ATA continues to be the leading worldwide organization dedicated to research into, and diagnosis and treatment of, various thyroid disorders. US ENDOCRINOLOGY has a high impact factor and is the foremost thyroid journal worldwide.
Clinical Thyroidology, provides research and clinical summaries to the scientific community, and Clinical Thyroidology for Patients, which modifies these articles for public and patients, both remain very popular.
My duties this year included bimonthly ATA Board conference calls as well as bimonthly Executive Committee calls. These calls, and many emails, increased contacts within the ATA leadership and facilitated our operations and functions. We took care of frequent interview requests from the media, mostly magazines, to explain or expand on thyroid topics such as soy, diet, iodine and thyroid; radiation and cancer; thyroid function and treatment in pregnancy; subclinical thyroid disease; selenium use; and more. Our dedicated ATA staff provided excellent administrative support for our many ongoing programs and activities.
As I reflect on our achievements this past year, I am proud of the fact that we provided stable and progressive leadership to the ATA, completed several guidelines, successfully launched VideoEndocrinology (VE), planned and executed an outstanding annual meeting with a record attendance, maintained high ATA visibility, increased our membership, and remain financially strong. It is hoped that VE, an innovative approach, will provide educational, high-quality cases, debates, or procedures for endocrinologists. As President, I think I helped to advance the ATA vision and mission. However, despite our accomplishments over an apparently successful year, I believe we need to be vigilant, remaining able to adapt and respond to a rapidly evolving healthcare landscape with shrinking resources.
In closing, it is not possible for me to acknowledge all those who have helped me throughout my life, but I would like to thank my family for their lasting and unwavering support, my colleagues who continue to teach me, my residents and fellows who inspire me, and, above all, my patients, from whom I have learnt, and still learn, a great deal.
A final thanks goes to America, incomparable land of opportunity, and to the ATA for this great honor. n
